SCHEMBL12759304

SCHEMBL12759304

CCCCCC1CCC(c2ccc(COc3ccc(OC)c(F)c3F)cc2)OC1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
CRHBP P24387 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
CRHR2 Q13324 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MRGPRX4 Q96LA9 1/20 0.34
SMPD1 P17405 1/20 0.33
BCHE P06276 1/20 0.32
LYPLA1 O75608 1/20 0.32
LYPLA2 O95372 1/20 0.32
ABHD16A O95870 1/20 0.32
PTAFR P25105 2/20 0.31
FASN P49327 1/20 0.31
NPC1 O15118 1/20 0.31
CSF1R P07333 4/20 0.31
KDM4E B2RXH2 1/20 0.31
APP P05067 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12759301 0.97 MAPT (0.37) MEN1MAPTCRHBPHTTKMT2A
SCHEMBL12759313 0.95 MAPT (0.33) MEN1MAPTCRHBPHTTKMT2A
SCHEMBL12759331 0.93 MAPT (0.35) MEN1MAPTCRHBPHTTKMT2A
SCHEMBL12759298 0.93 MRGPRX4 (0.36) MEN1MAPTCRHBPHTTKMT2A
SCHEMBL12759320 0.92 MEN1 (0.33) MEN1MAPTCRHBPHTTKMT2A
SCHEMBL12759310 0.92 MAPT (0.33) MEN1MAPTCRHBPHTTKMT2A
SCHEMBL12759319 0.89 MAPT (0.33) MEN1MAPTCRHBPHTTKMT2A
SCHEMBL12759295 0.88 MRGPRX4 (0.37) MEN1MAPTCRHBPHTTKMT2A
SCHEMBL12759307 0.87 FASN (0.37) MEN1MAPTCRHBPHTTKMT2A
SCHEMBL12759309 0.85 MRGPRX4 (0.34) MRGPRX4BCHEPTAFRNPC1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2272837-B1 LIQUID CRYSTALLINE COMPOUND WITH NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORP (JP) 2014-12-17 EP disclosed
US-7914862-B2 Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device CHISSO CORPORATION (JP) 2011-03-29 US disclosed
US-7914862-B2 Liquid crystal compound having negative dielectric anisotropy, liquid crystal composition, and liquid crystal display device CHISSO CORPORATION (JP) 2011-03-29 US disclosed
EP-2272837-A1 LIQUID CRYSTALLINE COMPOUND WITH NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE Chisso Corporation (JP) 2011-01-12 EP disclosed
US-20090278088-A1 LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2009-11-12 US disclosed
US-20090278088-A1 LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2009-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090278088-A1 LIQUID CRYSTAL COMPOUND HAVING NEGATIVE DIELECTRIC ANISOTROPY, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE OCIAD2, OCIAD1, CCDC22 MEN1 3564/4885MAPT 375/4885CRHBP 3555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.